NeuroPace (NPCE) Net Equity Issued and Repurchased (2024 - 2025)
NeuroPace (NPCE) posted quarterly Net Equity Issued and Repurchased of $69.4 million for Q4 2025, up 199.13% quarter-over-quarter from -$70.0 million in Q2 2025.
NeuroPace (NPCE) Net Equity Issued and Repurchased (2024 - 2025) Analysis & Trends
NeuroPace's Net Equity Issued and Repurchased history runs 2 years deep, the most recent figure standing at $69.4 million for Q4 2025.
- In Q4 2025, Net Equity Issued and Repurchased changed N/A year-over-year to $69.4 million; the TTM figure through Mar 2026 stood at -$611000.0 (down 100.83% YoY), while the FY2025 annual figure was $69.7 million, changed N/A from the prior year.
- Net Equity Issued and Repurchased for Q4 2025 stood at $69.4 million, up from -$70.0 million in the prior quarter.
- The five-year high for Net Equity Issued and Repurchased was $70.3 million in Q1 2025, with the low at -$70.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 97.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | - |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | - |
| 10 | NeuroPace | 479.51 Mn | 427.81 Mn | 18.91 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 69.42 Mn |
| Dec 31, 2025 | 69.42 Mn |
| Jun 30, 2025 | -70.03 Mn |
| Jun 30, 2025 | -70.03 Mn |
| Mar 31, 2025 | 70.27 Mn |
| Mar 31, 2025 | 70.27 Mn |
| Sep 30, 2024 | 3.00 Mn |
| Sep 30, 2024 | 3.00 Mn |